Bernstein Reiterates Outperform Rating on Regeneron Pharma (REGN) Following a Sell-side Q&A
Tweet Send to a Friend
Bernstein SocGen Group analyst William Pickering reiterated an Outperform rating and $1,070.00 price target on Regeneron Pharma (NASDAQ: REGN).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
